AUS
NZ
UK
CA
USA
IND
Healt
Telix Pharma Gains Traction on Radiopharma Progress
March 24, 2026 05:14 PM AEDT| By SamTelix Pharmaceuticals advances its radiopharma pipeline with key trial updates, strengthening its position in oncology innovation and drawing attention across broader ASX indices.
Recce Expands Global Patent Reach with Brazil Win
March 24, 2026 04:32 PM AEDT| By SamRecce Pharmaceuticals Ltd expands its global footprint with a Brazil patent, strengthening its anti-infectives platform and supporting innovation in treating bacterial and viral infections worldwide.
Emyria’s Mental Health Expansion Gains Momentum Ahead of Clinic Launch
March 24, 2026 12:29 PM AEDT| By SamMental health expansion gains traction as clinical readiness, workforce strength, and funded pathways align to support scalable healthcare delivery and improved patient access across Australia.
Echo IQ Gains Momentum on US Expansion Deal with Mayo Clinic
March 24, 2026 12:17 PM AEDT| By SamAI-driven healthcare innovation expands globally as advanced diagnostic tools integrate into hospital systems, highlighting regulatory progress, clinical validation, and growing demand for scalable solutions in modern medical ecosystems.
CHM.AX Crash Explained: What’s Driving Market Pressure Now
March 24, 2026 12:10 PM AEDT| By SamSharp movement in a biotech stock highlights liquidity risks, sector sentiment, and funding challenges, with future direction tied to clinical progress, market confidence, and broader healthcare trends.
Why CSL Faces Pressure While Pro Medicus Gains ASX 200 Focus
March 24, 2026 11:46 AM AEDT| By SamHealthcare sector shifts highlight innovation-led growth trends as established players face pressure while emerging technology-focused companies expand globally and strengthen their market presence.
Pro Medicus Update Sparks Fresh Valuation Debate
March 23, 2026 04:32 PM AEDT| By SamPro Medicus (ASX:PME) leadership changes spark renewed valuation debate as investors weigh growth outlook, premium pricing, and evolving healthcare imaging trends.
CSL Ltd (ASX:CSL) Holds Firm in ASX 50 on Continued Revenue Strength
March 23, 2026 03:55 PM AEDT| By SamCSL Ltd (ASX:CSL) delivers plasma, influenza, and renal treatments, maintains balanced financial metrics, and holds a key position among ASX 50 top companies.
Telix Pharmaceuticals (ASX:TLX) Advances Trials in ASX 100
March 23, 2026 03:49 PM AEDT| By SamTelix Pharmaceuticals (ASX:TLX) continues development of TLX101-Px and TLX591-Tx, highlighting regulatory progress and sector significance within the ASX 100.
Is Echo IQ (ASX:EIQ) Entry Reshaping ASX all ords?
March 23, 2026 03:05 PM AEDT| By SamEcho IQ joins the ASX all ords, reflecting increased healthcare technology participation and evolving market composition within Australia’s equity landscape.
Is Amplia Therapeutics (ASX:ATX) Advancing Cancer Trial Progress?
March 23, 2026 01:40 PM AEDT| By SamAmplia Therapeutics advances pancreatic cancer research through clinical trial progress, highlighting healthcare sector activity within the ASX All Ordinaries framework.
Island Pharma Share Move: What It Means Now
March 23, 2026 11:25 AM AEDT| By SamIsland Pharmaceuticals expands its share base through ASX quotation, highlighting capital flexibility and evolving liquidity dynamics within Australia’s healthcare-focused market environment.
ASX Healthcare Faces Pressure as Key Catalysts Drive Focus
March 20, 2026 05:48 PM AEDT| By SamASX healthcare stocks navigate macro pressures as clinical progress, regulatory updates, and innovation-driven milestones guide sector momentum and reshape market attention.
ASX 200 Update: Adherium Expands Through Share Move
March 20, 2026 04:38 PM AEDT| By Team Kalkine MediaAdherium strengthens its capital strategy through new share quotation, reflecting broader trends in healthcare innovation and evolving dynamics within Australia’s equity market.
CSL Limited (ASX:CSL) Expands US Capacity, Signals ASX20 Shift
March 20, 2026 04:36 PM AEDT| By SamCSL growth in the asx 20 reflects large scale manufacturing expansion, improved plasma processing efficiency, and alignment with global biotechnology trends shaping therapy production capacity.
Adherium Share Expansion Update Aligns with ASX 200
March 20, 2026 04:19 PM AEDT| By SamAdherium advances its capital structure with new share quotation activity, aligning with broader healthcare technology trends across the Australian equity market landscape.
Could Argent Biopharma Move Reshape ASX Healthcare Focus?
March 20, 2026 03:59 PM AEDT| By SamArgent Biopharma advances share quotation process, reflecting capital structure activity within ASX All Ords and supporting ongoing pharmaceutical development initiatives.
Is ASX 200 CSL Expansion Reshaping Pharma Sector?
March 20, 2026 01:28 PM AEDT| By SamCSL expands US manufacturing footprint, highlighting pharmaceutical sector activity and its influence across the All Ordinaries and broader market participation.
Vita Resources Advances ICE Project in Yukon
March 20, 2026 12:15 PM AEDT| By SamVita Resources advances its ICE project in Yukon following a key recommendation, highlighting exploration progress within the ASX All Ordinaries mining sector.
Alterity Therapeutics ASX Updates Capital Plan Amid Options Issue Move
March 19, 2026 07:19 PM AEDT| By SamAlterity Therapeutics outlines a structured options issuance plan on the ASX, highlighting its capital framework and role within the biotechnology sector and broader Australian market activity.
Advertise your brand on Kalkine Media